ASND CIK: 1612042

Ascendis Pharma A/S

  • Denmark
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions EUR
FY21:
0.81
FY22:
0.92
FY23:
0.70
FY24:
1.06
FY25:
1.11
(positive)
Change from FY21 to FY25
billions EUR
FY21:
0.28
FY22:
0.17
FY23:
0.12
FY24:
0.12
FY25:
0.19
Total assets
Change from FY21 to FY25
billions EUR
FY21:
1.08
FY22:
1.09
FY23:
0.83
FY24:
1.18
FY25:
1.30

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions EUR
FY21:
0.10
FY22:
0.17
FY23:
0.74
FY24:
0.91
FY25:
1.07
(negative)
Change from FY21 to FY25
billions EUR
FY21:
0.10
FY22:
0.66
FY23:
0.23
FY24:
0.38
FY25:
0.40
(positive)
Change from FY21 to FY25
billions EUR
FY21:
0.88
FY22:
0.26
FY23:
−0.15
FY24:
−0.11
FY25:
−0.16
Total liabilities & equity
Change from FY21 to FY25
billions EUR
FY21:
1.08
FY22:
1.09
FY23:
0.83
FY24:
1.18
FY25:
1.30

All amounts in billions EUR Data sources:SEC EDGARTwelve Data